Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01052116 · ClinicalTrials.gov registry record · Phase 4
The Study of Soy Isoflavones in Asthma
A Phase 4 study of Asthma, sponsored by American Lung Association Asthma Clinical Research Centers.
- Completed
- Registry status
- Phase 4
- Development phase
- 386
- Enrollment target
- 18
- Study locations
NCT01052116: Completed Phase 4 study of Asthma, sponsored by American Lung Association Asthma Clinical Research Centers.
NCT01052116 is a Phase 4 study of Asthma that has completed, run by American Lung Association Asthma Clinical Research Centers. The registered enrollment target is 386 participants, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (75% lower). The trial reports 18 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01052116, a Phase 4 study of Asthma, has completed, sponsored by American Lung Association Asthma Clinical Research Centers.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 386 participants
- Enrollment target
- 18
- Study locations
Study Summary
The trial is designed to study the effects of soy supplements on asthma control.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Soy isoflavone supplement
Study Locations (18)
Florida
- Nemours Children's Clinic - Jacksonville
- University of Miami School of Medicine - Miami
- University of South Florida College of Medicine - Tampa
New York
- North Shore - Long Island Jewish Health System - New Hyde Park
- New York University School of Medicine - New York
- New York Medical College - Valhalla
Missouri
- University of Missouri, Kansas City School of Medicine - Kansas City
- Washington University School of Medicine - St Louis
Arizona
- University of Arizona - Tucson
California
- University of California, San Diego - San Diego
Colorado
- National Jewish Health - Denver
Illinois
- Northwestern Memorial Hospital - Chicago
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 386 participants |
| Start Date | 2010-03 |
| Est. Completion | 2012-08 |
| Phase | Phase 4 |
What the finished NCT01052116 record still lists
NCT01052116 is an interventional study that assigns participants to a tested intervention. The registered 386 participants enrollment target is mid-sized for trials with a published cap, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01052116 lists 18 locations in 13 states (Florida, New York, Missouri).
Frequently Asked Questions
What is clinical trial NCT01052116 about?
NCT01052116 is a clinical study titled "The Study of Soy Isoflavones in Asthma". The trial is designed to study the effects of soy supplements on asthma control.
What is the current status of trial NCT01052116?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 386 participants. The study started on 2010-03. Estimated completion is 2012-08.
What conditions does trial NCT01052116 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT01052116?
The interventions under investigation include: Placebo (DRUG), Soy isoflavone supplement (DRUG).
Who is sponsoring clinical trial NCT01052116?
This trial is sponsored by American Lung Association Asthma Clinical Research Centers, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01052116 being conducted?
This trial has 18 study locations across Arizona, California, Colorado, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01052116's enrollment target sits among peer trials
386 99th of 374 higher than 275 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
-
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 4
-
Viral Infection in Asthma (VIA) Study
RECRUITING · Phase 4
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
RECRUITING · Phase 4
-
The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)
RECRUITING · Phase 4
-
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05645107 · 386 participants · Phase 3
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
- NCT05896189 · 386 participants · NA
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
- NCT06686121 · 386 participants · Phase 3
Improving Mobility After Revascularization in Peripheral Artery Disease
- NCT07424547 · 386 participants · Phase 1
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia